GO:0090319 positive regulation of chylomicron remodeling: Lipid Processing Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090319 describes any process that increases the rate, frequency, or extent of chylomicron remodeling, the acquisition, loss, or modification of protein or lipid within a chylomicron.
• Chylomicron remodeling includes hydrolysis of triglyceride by lipoprotein lipase and subsequent loss of free fatty acid, a central step in postprandial lipid clearance.
• Genetic and lifestyle factors jointly influence hypertriglyceridemia and chylomicron metabolism, as shown in large population studies such as UK Biobank and KoGES.
• The liver is a key site for lipoprotein processing, and cooperation among liver cell types supports lipid and lipoprotein homeostasis relevant to chylomicron remodeling.
• Dysregulation of chylomicron remodeling contributes to hypertriglyceridemia and related cardiometabolic risk, making it a target for precision nutrition and therapeutic research.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes proposed to regulate chylomicron remodeling.
Description
GO:0090319, positive regulation of chylomicron remodeling, is a biological process term that captures any mechanism increasing the rate, frequency, or extent of chylomicron remodeling. Chylomicrons are large triglyceride-rich lipoproteins assembled in the intestine after a meal, and their remodeling involves the acquisition, loss, or modification of proteins and lipids, including triglyceride hydrolysis by lipoprotein lipase and the subsequent loss of free fatty acid. Because this process directly affects postprandial lipid clearance, its positive regulation is central to understanding how the body handles dietary fat. Researchers study this term to connect genetic variation and lifestyle exposures to hypertriglyceridemia and cardiometabolic risk. Large-scale analyses integrating genetics and lifestyles, such as the UK Biobank and KoGES studies, have highlighted that both inherited and behavioral factors shape triglyceride handling and chylomicron metabolism. At the tissue level, the liver is a major hub for lipoprotein processing, and cooperation among liver cell types is required for normal lipid and lipoprotein homeostasis. Thus, GO:0090319 provides a focused framework for investigating how positive regulation of chylomicron remodeling is achieved and how its disruption contributes to disease.
positive regulation of chylomicron remodeling At A Glance
| GO ID | GO:0090319 |
|---|---|
| GO term | positive regulation of chylomicron remodeling |
| Ontology | biological_process |
| Synonym | positive regulation of chylomicron remodelling |
| Definition | Any process that increases the rate, frequency, or extent of chylomicron remodeling, the acquisition, loss or modification of a protein or lipid within a chylomicron, including the hydrolysis of triglyceride by lipoprotein lipase and the subsequent loss of free fatty acid. |
| Major function | Enhances postprandial processing and clearance of triglyceride-rich chylomicrons. |
| Related process | Chylomicron remodeling and lipid homeostasis. |
| Tissue context | Liver and intestine are key sites for lipoprotein processing and chylomicron metabolism. |
| Disease relevance | Hypertriglyceridemia and cardiometabolic risk. |
What Is GO:0090319?
In plain terms, GO:0090319 means any process that speeds up, increases the frequency of, or expands the extent of chylomicron remodeling. Chylomicron remodeling itself is the acquisition, loss, or modification of a protein or lipid within a chylomicron, including the hydrolysis of triglyceride by lipoprotein lipase and the subsequent loss of free fatty acid. Therefore, positive regulation of this term refers to mechanisms that enhance these remodeling events, thereby promoting the processing and clearance of triglyceride-rich lipoproteins after a meal.
Why Is positive regulation of chylomicron remodeling Important in Cell Biology?
GO:0090319 matters because positive regulation of chylomicron remodeling determines how efficiently dietary fat is processed and cleared from the circulation, and its dysregulation is linked to hypertriglyceridemia and related cardiometabolic conditions. Understanding this process helps researchers connect genetic and lifestyle factors to triglyceride handling, as demonstrated by integrated analyses in UK Biobank and KoGES. In addition, the liver's central role in lipoprotein metabolism and the cooperation among liver cell types underscore why tissue-level regulation of chylomicron remodeling is physiologically important.
• Defines a specific biological process for annotating genes that enhance chylomicron remodeling.
• Links postprandial triglyceride clearance to hypertriglyceridemia risk.
• Supports precision nutrition research by integrating genetic and lifestyle data.
• Highlights the liver as a key tissue for lipoprotein processing and homeostasis.
• Provides a framework for testing causal genes using CRISPR models.
• Helps interpret population-scale genetic associations with triglyceride traits.
• Guides therapeutic strategies targeting chylomicron metabolism.
• Enables mechanistic studies of lipoprotein lipase-mediated triglyceride hydrolysis.
• Connects cell-type cooperation in the liver to systemic lipid handling.
• Facilitates biomarker discovery for cardiometabolic risk.
What Happens During positive regulation of chylomicron remodeling?
Chylomicron assembly and secretion
In simple terms: Chylomicrons are built and released after a meal to carry dietary fat.
Chylomicrons are triglyceride-rich lipoproteins that are assembled and secreted to transport dietary lipids, and their subsequent remodeling is a key step in postprandial lipid handling. Positive regulation of chylomicron remodeling begins with the availability of these particles in the circulation, where they become substrates for modification. The liver also contributes to lipoprotein processing and overall lipid homeostasis, supporting the systemic context in which chylomicron remodeling occurs.
Triglyceride hydrolysis by lipoprotein lipase
In simple terms: Enzymes trim triglycerides from chylomicrons, releasing fatty acids.
A central event in chylomicron remodeling is the hydrolysis of triglyceride by lipoprotein lipase, which reduces the triglyceride content of the particle and releases free fatty acid. Positive regulation of this step increases the rate or extent of triglyceride breakdown, thereby accelerating the conversion of large triglyceride-rich chylomicrons into smaller remnant particles. This hydrolytic step is explicitly included in the definition of chylomicron remodeling.
Loss of free fatty acid and particle modification
In simple terms: After fat is removed, the chylomicron changes size and composition.
Following hydrolysis, the subsequent loss of free fatty acid from the chylomicron constitutes part of the remodeling process. Positive regulation of chylomicron remodeling therefore encompasses mechanisms that enhance the removal of fatty acids and the associated changes in particle composition. These modifications are essential for the particle's progression toward remnant formation and clearance.
Acquisition and modification of proteins and lipids
In simple terms: Chylomicrons exchange proteins and lipids with other lipoproteins.
Chylomicron remodeling is defined broadly as the acquisition, loss, or modification of a protein or lipid within a chylomicron, beyond triglyceride hydrolysis alone. Positive regulation of this term thus includes processes that increase the exchange or modification of apolipoproteins and lipids on the particle surface. Such changes influence particle fate and interactions with receptors and enzymes involved in lipid clearance.
Integration with hepatic lipid handling
In simple terms: The liver helps process the remnants left after chylomicron remodeling.
The liver is a major organ for lipoprotein metabolism, and cooperation among liver cell types supports lipid and lipoprotein homeostasis. Positive regulation of chylomicron remodeling is therefore integrated with hepatic processes that handle remnant particles and maintain systemic lipid balance. This tissue-level cooperation provides a physiological context for interpreting genetic and lifestyle influences on triglyceride handling.
Key Genes Involved in GO:0090319 positive regulation of chylomicron remodeling
The following genes and proteins are relevant to chylomicron remodeling and its positive regulation, based on their roles in lipoprotein metabolism and lipid handling as described in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LPL | Hydrolyzes triglyceride in chylomicrons, a core remodeling step | Target for studying positive regulation of chylomicron remodeling |
| APOC2 | Modulates lipoprotein lipase activity and triglyceride hydrolysis | Candidate for functional studies of chylomicron remodeling |
| APOA5 | Influences triglyceride metabolism and lipoprotein processing | Genetic studies of hypertriglyceridemia |
| APOE | Participates in lipoprotein remodeling and clearance | Association studies with lipid traits |
| APOB | Structural apolipoprotein of triglyceride-rich lipoproteins | Research on chylomicron assembly and remodeling |
| LMF1 | Supports lipoprotein lipase maturation and function | Functional validation in lipid metabolism |
| GPIHBP1 | Anchors lipoprotein lipase at the capillary endothelium | Mechanistic studies of triglyceride hydrolysis |
| ANGPTL3 | Regulates lipoprotein lipase activity and triglyceride levels | Therapeutic target for hypertriglyceridemia |
| ANGPTL4 | Modulates lipoprotein lipase and lipid handling | Research on positive regulation of remodeling |
| APOC3 | Inhibits lipoprotein lipase and affects triglyceride clearance | Genetic and pharmacological studies |
| CREBH | Transcription factor involved in hepatic lipid metabolism | Liver-focused mechanistic studies |
| PPARA | Regulates lipid metabolism genes in the liver | Studies of hepatic lipid handling |
| SREBF1 | Controls lipogenic gene expression | Research on hepatic lipid homeostasis |
| NR1H3 | Nuclear receptor regulating lipid metabolism | Liver cell cooperation studies |
| FABP1 | Binds fatty acids in the liver | Studies of hepatic fatty acid handling |
| CD36 | Facilitates fatty acid uptake | Research on lipid uptake and remodeling |
| LIPC | Hepatic lipase involved in lipoprotein remodeling | Functional studies of remnant processing |
How Is positive regulation of chylomicron remodeling Regulated?
Positive regulation of chylomicron remodeling is influenced by both genetic and lifestyle factors that jointly determine triglyceride handling and hypertriglyceridemia risk. Population-scale analyses integrating genetics and lifestyles, such as UK Biobank and KoGES, demonstrate that inherited variants and behavioral exposures interact to shape lipid traits relevant to chylomicron metabolism. At the tissue level, the liver coordinates lipoprotein processing through cooperation among its cell types, providing a regulatory environment for chylomicron remodeling.
positive regulation of chylomicron remodeling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LPL | Hypertriglyceridemia and impaired triglyceride hydrolysis | Knockout or point-mutation cell model |
| APOC2 | Hypertriglyceridemia via altered lipoprotein lipase regulation | Knock-in of patient variants |
| APOA5 | Elevated triglycerides and cardiometabolic risk | Overexpression and knockout models |
| ANGPTL3 | Hypertriglyceridemia and lipid disorders | Knockout and point-mutation models |
| APOC3 | Hypertriglyceridemia and impaired clearance | Knockout and overexpression models |
Hypertriglyceridemia
Hypertriglyceridemia is a condition in which triglyceride levels are elevated, and it is influenced by both genetic and lifestyle factors that affect chylomicron metabolism and remodeling. Integrated analyses in UK Biobank and KoGES have shown that precision nutrition approaches can help stratify individuals based on genetic and lifestyle contributions to hypertriglyceridemia. Positive regulation of chylomicron remodeling is therefore directly relevant to understanding and managing this disorder.
Cardiometabolic risk
Altered chylomicron remodeling contributes to cardiometabolic risk through its effects on postprandial lipid clearance and triglyceride-rich lipoprotein levels. Genetic and lifestyle factors that modify chylomicron remodeling can therefore influence overall cardiometabolic health. Studying positive regulation of this process helps identify pathways for risk assessment and intervention.
Hepatic lipid disorders
The liver plays a central role in lipoprotein metabolism, and cooperation among liver cell types is required for normal lipid and lipoprotein homeostasis. Disruption of hepatic lipid handling can affect the processing of chylomicron remnants and related lipoproteins. Thus, liver-focused research is important for understanding how positive regulation of chylomicron remodeling relates to hepatic lipid disorders.
From positive regulation of chylomicron remodeling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene increase chylomicron remodeling? | CRISPR knockout cell model |
| Does a specific variant alter lipoprotein lipase function? | Point-mutation knock-in model |
| Does overexpression of a gene enhance triglyceride hydrolysis? | Overexpression cell model |
| How does a tagged protein localize during remodeling? | Tagged knock-in model |
| Which liver cell types cooperate in lipid handling? | Co-culture models of liver cells |
| Can genetic and lifestyle factors be integrated for precision nutrition? | Population-scale data analysis with functional validation |
How to Study the positive regulation of chylomicron remodeling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Loss-of-function effects on lipid handling | Identifying positive regulators of chylomicron remodeling |
| CRISPR knock-in | Effects of specific variants | Testing patient-derived mutations |
| Overexpression | Gain-of-function effects | Assessing enhanced remodeling |
| Lipid profiling | Triglyceride and lipoprotein levels | Phenotyping hypertriglyceridemia models |
| Population genetics | Genetic associations with lipid traits | Precision nutrition research |
| Liver cell co-culture | Cell-type cooperation in lipid handling | Studying hepatic lipoprotein metabolism |
| Transcriptomics | Gene expression changes | Identifying hepatic lipid pathways |
| Proteomics | Protein composition of lipoproteins | Characterizing remodeling changes |
Genomic and population-scale analysis
Large-scale genetic and lifestyle analyses, such as those using UK Biobank and KoGES, can identify variants and exposures associated with hypertriglyceridemia and chylomicron metabolism. These approaches help prioritize candidate genes for functional studies of positive regulation of chylomicron remodeling.
CRISPR functional screens
CRISPR knockout and knock-in screens enable systematic testing of genes for their effects on lipid handling and chylomicron remodeling. Such screens can reveal positive regulators of triglyceride hydrolysis and particle modification.
Liver cell and tissue models
Because the liver is a key site for lipoprotein metabolism and cooperation among liver cell types supports lipid homeostasis, liver-derived cell models are valuable for studying chylomicron remodeling. These models allow investigation of hepatic contributions to positive regulation of this process.
Lipid and lipoprotein assays
Measuring triglyceride levels and lipoprotein profiles provides readouts for chylomicron remodeling activity. Combining these assays with genetic perturbation helps establish causal relationships.
How CRISPR Can Be Used to Study GO:0090319 positive regulation of chylomicron remodeling
Knockout
CRISPR knockout models can eliminate candidate genes to test whether they are required for positive regulation of chylomicron remodeling. Loss-of-function studies help determine causality between a gene and triglyceride handling.
Point Mutation
Point-mutation models introduce specific variants to assess their impact on chylomicron remodeling and lipid metabolism. These models are useful for studying patient-derived mutations associated with hypertriglyceridemia.
Knock-in
Knock-in strategies can insert tags or disease-associated alleles to monitor protein localization and function during chylomicron remodeling. They enable precise interrogation of gene variants in a physiological context.
Overexpression
Overexpression models increase gene dosage to test whether a candidate gene enhances chylomicron remodeling. Such gain-of-function studies complement knockout approaches.
How EDITGENE Supports positive regulation of chylomicron remodeling Research
Researchers studying positive regulation of chylomicron remodeling-related genes often need to determine whether a candidate gene is causally involved in lipid handling or simply associated with triglyceride traits. EDITGENE provides CRISPR-based cell models and screening services to support such causal investigations.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of chylomicron remodeling research.
Frequently Asked Questions About positive regulation of chylomicron remodeling
What is GO:0090319?
GO:0090319 is the Gene Ontology term for positive regulation of chylomicron remodeling, defined as any process that increases the rate, frequency, or extent of chylomicron remodeling.
What is chylomicron remodeling?
Chylomicron remodeling is the acquisition, loss, or modification of a protein or lipid within a chylomicron, including triglyceride hydrolysis by lipoprotein lipase and loss of free fatty acid.
What genes are involved in positive regulation of chylomicron remodeling?
Genes such as LPL, APOC2, APOA5, APOC3, ANGPTL3, and others involved in lipoprotein metabolism are relevant to this process.
Why is positive regulation of chylomicron remodeling important?
It affects postprandial lipid clearance and is linked to hypertriglyceridemia and cardiometabolic risk.
How is chylomicron remodeling studied?
It can be studied using genetic and lifestyle analyses, CRISPR functional screens, and lipid profiling assays.
What diseases are associated with chylomicron remodeling?
Hypertriglyceridemia and related cardiometabolic conditions are associated with altered chylomicron metabolism.
Does the liver play a role in chylomicron remodeling?
Yes, the liver is a major site for lipoprotein metabolism, and cooperation among liver cell types supports lipid homeostasis.
Can CRISPR be used to study chylomicron remodeling?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models can test gene function in this process.
What is the synonym for GO:0090319?
The synonym is positive regulation of chylomicron remodelling.
How can precision nutrition relate to chylomicron remodeling?
Integrating genetics and lifestyles, as in UK Biobank and KoGES analyses, helps tailor approaches to hypertriglyceridemia and lipid handling.
Conclusion
GO:0090319, positive regulation of chylomicron remodeling, defines a biologically important process that enhances the modification and clearance of triglyceride-rich lipoproteins. Its relevance spans hypertriglyceridemia, cardiometabolic risk, and hepatic lipid handling, with genetic and lifestyle factors jointly shaping outcomes. CRISPR-based models and population-scale analyses provide complementary tools to dissect the mechanisms and causal genes underlying this process.
References
- 1. Hur HJ et al.. 2025. Integrating genetics and lifestyles for precision nutrition in hypertriglyceridemia: A UK Biobank and KoGES analysis.. J Clin Lipidol 19(4):942-959 PMID: 40517091
- 2. Kmieć Z. 2001. Cooperation of liver cells in health and disease.. Adv Anat Embryol Cell Biol 161:III-XIII, 1-151 PMID: 11729749
